The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity

被引:68
作者
Chen, XG
Wolin, SL
机构
[1] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, New Haven, CT 06536 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys, New Haven, CT 06536 USA
[3] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, New Haven, CT 06536 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2004年 / 82卷 / 04期
关键词
autoimmunity; lupus; RNA; Ro 60 kDa protein; ultraviolet irradiation;
D O I
10.1007/s00109-004-0529-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An RNA-binding protein, the Ro 60 kDa antoantigen, is a major target of the immune response in patients suffering from two systemic rheumatic diseases, systemic lupus erythematosus and Sjogren's syndrome. In lupus patients, anti-Ro antibodies are associated with photosensitive skin lesions and with neonatal lupus, a syndrome in which mothers with anti-Ro antibodies give birth to children with photosensitive skin lesions and a cardiac conduction defect, third degree heart block. In vertebrate cells, the Ro protein binds small RNAs of unknown function known as Y RNAs. Although the cellular function of Ro has long been mysterious, recent studies have implicated Ro in two distinct processes: small RNA quality control and the enhancement of cell survival following exposure to ultraviolet irradiation. Most interestingly, mice lacking the Ro protein develop an autoimmune syndrome that shares some features with systemic lupus erythematosus in patients, suggesting that the normal function of Ro may be important for the prevention of this autoimmune disease. In this review, we summarize recent progress towards understanding the role of the Ro 60 kDa protein and discuss whether the cellular function of Ro could be related to certain manifestations of lupus in patients.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 93 条
[41]   Neonatal lupus: clinical features, therapy, and pathogenesis. [J].
Lee L.A. .
Current Rheumatology Reports, 2001, 3 (5) :391-395
[42]   THE AUTOANTIBODY RESPONSE TO RO/SSA IN CUTANEOUS LUPUS-ERYTHEMATOSUS [J].
LEE, LA ;
ROBERTS, CM ;
FRANK, MB ;
MCCUBBIN, VR ;
REICHLIN, M .
ARCHIVES OF DERMATOLOGY, 1994, 130 (10) :1262-1268
[43]  
LEE LA, 1999, J INVEST DERMATOL S, P73
[44]   ULTRAVIOLET-LIGHT INDUCES BINDING OF ANTIBODIES TO SELECTED NUCLEAR ANTIGENS ON CULTURED HUMAN KERATINOCYTES [J].
LEFEBER, WP ;
NORRIS, DA ;
RYAN, SR ;
HUFF, JC ;
LEE, LA ;
KUBO, M ;
BOYCE, ST ;
KOTZIN, BL ;
WESTON, WL .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) :1545-1551
[45]   2 NOVEL CLASSES OF SMALL RIBONUCLEOPROTEINS DETECTED BY ANTIBODIES ASSOCIATED WITH LUPUS-ERYTHEMATOSUS [J].
LERNER, MR ;
BOYLE, JA ;
HARDIN, JA ;
STEITZ, JA .
SCIENCE, 1981, 211 (4480) :400-402
[46]   A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q [J].
Lindqvist, AKB ;
Steinsson, K ;
Johanneson, B ;
Kristjánsdóttir, H ;
Arnasson, A ;
Gröndal, G ;
Jonasson, I ;
Magnusson, V ;
Sturfelt, G ;
Truedsson, L ;
Svenungsson, E ;
Lundberg, I ;
Terwilliger, JD ;
Gyllensten, UB ;
Alarcón-Riquelme, ME .
JOURNAL OF AUTOIMMUNITY, 2000, 14 (02) :169-178
[47]   The FBP interacting repressor targets TFIIH to inhibit activated transcription [J].
Liu, JH ;
He, LS ;
Collins, I ;
Ge, H ;
Libutti, D ;
Li, JF ;
Egly, JM ;
Levens, D .
MOLECULAR CELL, 2000, 5 (02) :331-341
[48]   Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo [J].
Liu, Y ;
Snow, BE ;
Hande, MP ;
Baerlocher, G ;
Kickhoefer, VA ;
Yeung, D ;
Wakeham, A ;
Itie, A ;
Siderovski, DP ;
Lansdorp, PM ;
Robinson, MO ;
Harrington, L .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) :8178-8184
[49]   DIFFERENTIAL CONTROL OF U1 SMALL NUCLEAR-RNA EXPRESSION DURING MOUSE DEVELOPMENT [J].
LUND, E ;
KAHAN, B ;
DAHLBERG, JE .
SCIENCE, 1985, 229 (4719) :1271-1275
[50]   THE RO RIBONUCLEOPROTEIN PARTICLE - INDUCTION OF AUTOANTIBODIES AND THE DETECTION OF RO RNAS AMONG SPECIES [J].
MAMULA, MJ ;
OBRIEN, CA ;
HARLEY, JB ;
HARDIN, JA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (03) :435-446